EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Pulmonary Transit Time Derived from First‐Pass Perfusion Cardiac MR Imaging: A Potential New Marker for Cardiac Involvement and Prognosis in Light‐Chain Amyloidosis

Keying Bi, Ke Wan, Yuanwei Xu, Jie Wang, Weihao Li, Jiajun Guo, Ziqian Xu, Yangjie Li, Qiao Deng, Wei Cheng, Jiayu Sun, Yucheng Chen iD

Journal of Magnetic Resonance Imaging · 2024

DOI: 10.1002/jmri.29135 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Keying Bi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: The 1·3·5 Project for Disciplines of Excellence, West China Hospital, Sichuan University, National Natural Science Foundation of China, Post Doctor Research Project, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

First‐pass perfusion cardiac MR imaging could reflect pulmonary hemodynamics. However, the clinical value of pulmonary transit time (PTT) derived from first‐pass perfusion MRI in light‐chain (AL) amyloidosis requires further evaluation.

Purpose

To assess the clinical and prognostic value of PTT in patients with AL amyloidosis. Study Type Prospective observational study. Population 226 biopsy‐proven systemic AL amyloidosis patients (age 58.62 ± 10.10 years, 135 males) and 43 healthy controls (age 42 ± 16.2 years, 20 males). Field Strength/Sequence SSFP cine and phase sensitive inversion recovery late gadolinium enhancement (LGE) sequences, and multislice first‐pass myocardial perfusion imaging with a saturation recovery turbo fast low‐angle shot (SR‐TurboFLASH) pulse sequence at 3.0T. Assessment PTT was measured as the time interval between the peaks of right and left ventricular cavity arterial input function curves on first‐pass perfusion MR images. Statistical Tests Independent‐sample t test, Mann–Whitney U test, Chi‐square test, Fisher's exact test, analysis of variance, or Kruskal–Wallis test, as appropriate; univariable and multivariable Cox proportional hazards models and Kaplan–Meier curves, area under receiver operating characteristic curve were used to determine statistical significance.

Results

PTT could differentiate AL amyloidosis patients with ( N = 188) and without ( N = 38) cardiac involvement (area under the curve [AUC] = 0.839). During a median follow‐up of 35 months, 160 patients (70.8%) demonstrated all‐cause mortality. After adjustments for clinical (Hazard ratio [HR] 1.061, confidence interval [CI]: 1.021–1.102), biochemical (HR 1.055, CI: 1.014–1.097), cardiac MRI‐derived (HR 1.077, CI: 1.034–1.123), and therapeutic (HR 1.063, CI: 1.024–1.103) factors, PTT predicted mortality independently in patients with AL amyloidosis. Finally, PTT could identify worse outcomes in patients demonstrating New York Heart Association class III, Mayo 2004 stage III, and transmural LGE pattern. Data Conclusion PTT may serve as a new imaging predictor of cardiac involvement and prognosis in AL amyloidosis. Level of Evidence 2 Technical Efficacy Stage 2

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin Light-chain AmyloidosisHumansMaleFemaleMiddle AgedPrognosisProspective StudiesAdultAgedMyocardial Perfusion ImagingMagnetic Resonance ImagingHeartContrast MediaMagnetic Resonance Imaging, CineROC CurveAmyloidosisGadolinium

Stichwörter der Autor:innen

cardiaclight‐chain amyloidosisprognosispulmonary transit time

Substanzen

Contrast MediaGadolinium

Autor:innen und Institutionen

  • Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Geriatrics and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

ORCID-Profile: Yucheng Chen

Förderung

  • The 1·3·5 Project for Disciplines of Excellence, West China Hospital, Sichuan University
  • National Natural Science Foundation of China
  • Post Doctor Research Project, West China Hospital, Sichuan University

Zitieren

APA

Bi, K., Wan, K., Xu, Y., Wang, J., Li, W., Guo, J., Xu, Z., Li, Y., Deng, Q., Cheng, W., Sun, J., & Chen, Y. (2024). Pulmonary Transit Time Derived from First‐Pass Perfusion Cardiac MR Imaging: A Potential New Marker for Cardiac Involvement and Prognosis in Light‐Chain Amyloidosis. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29135

Vancouver

Bi K, Wan K, Xu Y, Wang J, Li W, Guo J, et al. Pulmonary Transit Time Derived from First‐Pass Perfusion Cardiac MR Imaging: A Potential New Marker for Cardiac Involvement and Prognosis in Light‐Chain Amyloidosis. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.29135

BibTeX
@article{Bi2024,
  author = {Bi, Keying and Wan, Ke and Xu, Yuanwei and Wang, Jie and Li, Weihao and Guo, Jiajun and Xu, Ziqian and Li, Yangjie and Deng, Qiao and Cheng, Wei and Sun, Jiayu and Chen, Yucheng},
  title = {Pulmonary Transit Time Derived from First‐Pass Perfusion Cardiac MR Imaging: A Potential New Marker for Cardiac Involvement and Prognosis in Light‐Chain Amyloidosis},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2024},
  doi = {10.1002/jmri.29135}
}
Kostenlos starten →